WallStreetZenWallStreetZen

NASDAQ: ALZN
Alzamend Neuro Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Alzamend Neuro revenue was $0.00 for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Jan 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Apr 30, 2024, ALZN annual revenue was $0.0, with N/A growth year-over-year.

ALZN revenue history

Current Revenue
$0.0
Current Earnings
-$4.3M
Current Profit Margin
0%

Be the first to know when ALZN announces revenue.

ALZN Revenue History By Year

ALZN Yearly RevenueALZN RevenueALZN ChangeALZN Revenue Growth
2024-04-30$0.00N/AN/A
2023-04-30$0.00N/AN/A
2022-04-30$0.00N/AN/A
2021-04-30$0.00N/AN/A
2020-04-30$0.00N/AN/A
2019-04-30$0.00N/AN/A

1 of 1

Alzamend Neuro Revenue FAQ

What was ALZN's revenue last quarter?

On Invalid Date, Alzamend Neuro (NASDAQ: ALZN) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Alzamend Neuro's revenue was $0.00.

What was Alzamend Neuro's revenue in 2024?

Alzamend Neuro's annual revenue for the twelve months ending Apr 30, 2024 was $0.00, a N/A decrease year over year.

How much does Alzamend Neuro make in a day?

Based on Alzamend Neuro annual revenue for the past five years, ALZN makes an average of $0.00 per day.

What was Alzamend Neuro's annual revenue growth in the past year?

As of Q2 2025, Alzamend Neuro's revenue has grown null year over year. Alzamend Neuro's revenue in the past year totaled $0.00.

How much does Alzamend Neuro make in a year?

Alzamend Neuro's revenue by year for the past five years is:
  • Alzamend Neuro's revenue for the twelve months ending Apr 30, 2024 was $0.00, a N/A decrease year over year.
  • Alzamend Neuro's annual revenue for Apr 30, 2023 was $0.00, a N/A decrease from 2022.
  • Alzamend Neuro's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Alzamend Neuro's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Alzamend Neuro's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.